0.3654
Precedente Chiudi:
$0.3627
Aprire:
$0.36
Volume 24 ore:
683.07K
Relative Volume:
0.03
Capitalizzazione di mercato:
$22.35M
Reddito:
$7.11M
Utile/perdita netta:
$-41.28M
Rapporto P/E:
-0.2648
EPS:
-1.38
Flusso di cassa netto:
$-26.84M
1 W Prestazione:
+2.92%
1M Prestazione:
-5.99%
6M Prestazione:
+25.86%
1 anno Prestazione:
-56.45%
Co Diagnostics Inc Stock (CODX) Company Profile
Nome
Co Diagnostics Inc
Settore
Industria
Telefono
(801) 278-9769
Indirizzo
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Confronta CODX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CODX
Co Diagnostics Inc
|
0.367 | 22.09M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
122.69 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.55 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
350.56 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.34 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.70 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-12 | Downgrade | Sidoti | Buy → Neutral |
| 2021-12-29 | Iniziato | Sidoti | Buy |
| 2021-03-29 | Downgrade | Maxim Group | Buy → Hold |
| 2020-05-20 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025 - PR Newswire
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India - cnhinews.com
Co Diagnostics Inc Stock Analysis and ForecastPrice Action Analysis & Build a Smarter Portfolio Right Now - earlytimes.in
Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN
Co-Diagnostics approves reverse stock split proposal - MSN
Co-Diagnostics Approves Reverse Stock Split Proposal - TipRanks
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - MSN
Co-Diagnostics (CODX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Operating cash flow per share of Co-Diagnostics, Inc. – HAN:C97 - TradingView
Profit Review: Is Co Diagnostics Inc. stock attractive for retirement portfoliosTrade Exit Report & Verified Momentum Stock Alerts - BỘ NỘI VỤ
Is Co Diagnostics Inc. a good long term investmentContrarian Investment Ideas & Build Wealth Brick by Brick With Us - earlytimes.in
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt
Maxim Group initiates coverage on Co-Diagnostics stock with Buy rating - Investing.com Canada
Maxim Group Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics (CODX) Initiated with 'Buy' Rating by Maxim Group - GuruFocus
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - MSN
[Form 4] Co-Diagnostics, Inc. Insider Trading Activity - Stock Titan
CFO Brown Surrenders 40,723 Of Co-Diagnostics Inc [CODX] - TradingView
Chmn Egan Surrenders 49,575 Of Co-Diagnostics Inc [CODX] - TradingView
Pres Abbott Surrenders 17,200 Of Co-Diagnostics Inc [CODX] - TradingView
HC Wainwright Reiterates Neutral Rating for Co-Diagnostics (CODX - GuruFocus
Can Co Diagnostics Inc. stock hit analyst price targets2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Will Co Diagnostics Inc. stock attract ESG investorsEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - newser.com
Would You Still Hold Co-Diagnostics Stock If It Fell Another 30%? - Trefis
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption - GuruFocus
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - The Herald Journal
Developing predictive dashboards with Co Diagnostics Inc. dataDollar Strength & Fast Moving Stock Trade Plans - newser.com
Co-Diagnostics (NASDAQ: CODX) Details Co-Dx PCR MTB Test Plans for 30,000 India Clinics - Stock Titan
Chart overlay techniques for tracking Co Diagnostics Inc.Earnings Recap Report & Daily Profit Maximizing Tips - newser.com
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - AOL.com
Predicting Co Diagnostics Inc. trend using moving averagesWeekly Loss Report & Safe Capital Growth Tips - newser.com
Why Co Diagnostics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
MSN Money - MSN
What technical models suggest about Co Diagnostics Inc.’s comebackTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Will Co Diagnostics Inc. stock benefit from AI adoptionWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
How sentiment analysis helps forecast Co Diagnostics Inc.2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN
How Co Diagnostics Inc. stock trades during market volatilityWeekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com
Co-Diagnostics Inc. (CODX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dxtm PCR Platform to Support Submission to the U.S. FDA - Lelezard
Co-Diagnostics Initiates Clinical Evaluations for Upper Respirat - GuruFocus
Co-Diagnostics initiates clinical evaluations for upper respiratory multiplex point-of-care test on Co-Dx(TM) PCR platform to support submission to the U.S. FDA - MarketScreener
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA - PR Newswire
Co Diagnostics Inc Azioni (CODX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):